Red Light Therapy for Hip Pain: What the Research Shows

By Chris Bohler Last updated: April 2026 8 min read
20+ years of research ✓ FDA 510(k) Cleared 4.8/5 rating 30-days free trial

Hip pain disrupts daily life—climbing stairs, getting out of bed, walking for exercise, even sitting comfortably becomes difficult. Whether the cause is osteoarthritis, bursitis, muscle strain, or labral tears, hip pain demands effective treatment. For decades, the options were limited: NSAIDs, injections, or surgery. Red light therapy offers a non-invasive, drug-free alternative. Evidence suggests photobiomodulation may reduce hip pain and improve function, especially when combined with physical therapy. This guide explores the research, explains the mechanism, and shows you how to use the MOVE+ for hip pain.

How Red Light Therapy Works for Hip Pain

Red light therapy works through photobiomodulation—a process in which near-infrared photons stimulate cellular mitochondria. The hip joint is complex: it includes bone, cartilage, synovial fluid, ligaments, tendons, and muscle. Pain arises when these structures are inflamed, damaged, or degenerated.

When 808nm light from the MOVE+ penetrates hip tissue, it interacts with cytochrome c oxidase in mitochondrial complex IV. This interaction increases ATP (cellular energy) production, which fuels repair processes. Simultaneously, photobiomodulation reduces oxidative stress and pro-inflammatory cytokines—the signaling molecules that drive pain and swelling.

The result is a cascade of healing effects: reduced inflammation in the joint capsule and synovial membrane, improved cartilage metabolism, enhanced blood flow to the area, and decreased nerve sensitization. Over time, these changes translate to less pain, better range of motion, and improved function.

Clinical Evidence for Hip Pain

While hip-specific randomized controlled trials are limited, the evidence base for photobiomodulation in joint pain is robust. The strongest clinical data comes from knee osteoarthritis research, and the mechanisms of joint pathology and healing are shared across large joints.

A landmark 2019 meta-analysis in Arthritis Research & Therapy examined low-level laser therapy for knee osteoarthritis and found that LLLT reduces pain and disability in knee osteoarthritis at 4–8J with 785–860nm wavelength. This is the standard dose-response that applies to other joint conditions as well.

A comprehensive 2021 review in the Journal of Lasers in Medical Science examined photobiomodulation across multiple musculoskeletal conditions and found that PBM reduces pain across multiple musculoskeletal conditions and body regions, including joints affected by inflammation and degeneration.

A 2018 systematic review in Lasers in Medical Science examined photobiomodulation for muscular performance and recovery, showing that PBM improves recovery and reduces inflammation in muscles surrounding the joint. Strong hip muscles stabilize the joint and reduce compensatory pain patterns.

While direct hip OA trials are limited, the convergence of evidence from knee OA, soft tissue injury, and inflammatory joint conditions suggests that photobiomodulation is likely effective for hip pain as well. Clinical practitioners have reported positive outcomes with hip pain treatment using red light therapy, and many patients report significant pain relief after 4–8 weeks of consistent use.

Hip Conditions RLT May Help

Chris Bohler Wear-and-tear degeneration of the hip cartilage. RLT reduces pain, improves function, and may slow further degeneration. Evidence from knee OA translates directly to hip OA.

Hip bursitis: Inflammation of the fluid-filled sac (bursa) on the outside of the hip. RLT reduces inflammation and promotes tissue healing. Results are often rapid—2–3 weeks of treatment.

Muscle strain and tendonitis: Hip flexor strain, piriformis syndrome, and other muscle injuries respond well to photobiomodulation. RLT enhances muscle recovery and reduces pain.

Post-surgical hip pain: After hip arthroscopy or labral repair (after initial healing period, typically 6+ weeks), RLT can accelerate recovery and reduce post-operative inflammation.

Femoroacetabular impingement (FAI): Structural mismatch between femur and hip socket causing pain with certain movements. While RLT cannot alter bone structure, it can reduce inflammation and pain, improving function and quality of life.

Using the MOVE+ for Osteoarthritis

Device positioning: Position the MOVE+ over the lateral hip (outer side of the hip bone), the anterior hip (groin area for front-of-hip pain), or wherever pain is most acute. Keep the device 2–4 inches from skin. It works through light clothing, but direct skin contact is ideal.

Treatment duration: Start with 10–15 minutes per session. Some users find 15 minutes optimal for hip pain; others respond to 10 minutes. Do not exceed 15 minutes without consulting a practitioner.

Frequency: Begin with 3–4 times per week. After 2–3 weeks, reassess. If significant improvement, maintain 3x weekly. If minimal response, increase to 5x weekly for another 2 weeks. For mild hip pain, 2–3 times weekly may suffice.

Timeline to results: Most people notice initial improvements within 2–4 weeks. Chronic hip pain or severe OA may take 6–8 weeks. Consistency is critical—sporadic use delays results.

Combination approach: Red light therapy works best alongside physical therapy, stretching, and low-impact exercise. The MOVE+ reduces pain and inflammation, making it easier to engage in rehabilitation. Strengthen hip stabilizer muscles (glutes, hip abductors, hip external rotators) to improve joint stability and reduce compensatory patterns.

Safety considerations: RLT is well-tolerated. Some people experience mild warmth at the treatment site (normal and therapeutic). Avoid treating over acute fractures or open wounds. Do not use if you have a recent (< 6 weeks) hip replacement or surgical repair without physician approval.

Frequently Asked Questions

Can red light therapy help with hip pain? +
Evidence suggests red light therapy may reduce hip pain and stiffness in joint conditions. The strongest clinical evidence comes from knee osteoarthritis research, and the same mechanisms of action—improved cellular energy, reduced inflammation, and enhanced tissue repair—apply to hip joints. Studies show photobiomodulation at 4–8J with 785–860nm wavelengths is effective. While more hip-specific research is needed, the evidence supporting RLT for joint pain translates well to hip applications.
How does photobiomodulation reduce hip inflammation? +
Red light therapy works at the cellular level. Near-infrared photons (808nm) penetrate joint tissue and interact with mitochondrial cytochrome c oxidase, boosting ATP production. Increased cellular energy enhances the body's natural repair processes, reduces oxidative stress, and lowers pro-inflammatory cytokines. This mechanism decreases swelling in the joint capsule and synovial fluid, improves cartilage health, and reduces nerve sensitization—all contributing to pain relief and improved mobility.
How do I use the MOVE+ for hip pain? +
Position the MOVE+ directly over the hip joint (outer hip, lateral hip, or anterior hip depending on pain location) at a distance of 2–4 inches. Treat for 10–15 minutes, 4–5 times per week initially. Start conservatively (2–3 times weekly) to monitor response. The device can be used over light clothing. For best results, combine red light therapy with gentle movement, stretching, or physical therapy. Most users report improvements within 2–4 weeks.
How long before I notice results for hip pain? +
Response timelines vary, but most people notice initial improvements within 2–4 weeks of consistent treatment (3–5 times per week). Some experience relief within 1–2 weeks, while others require 6–8 weeks for substantial pain reduction. Chronic hip pain or severe osteoarthritis may take longer to respond. Consistency matters: irregular use delays results. Combining red light therapy with physical therapy, movement, and anti-inflammatory practices accelerates recovery.
Is red light therapy effective for hip osteoarthritis? +
Studies strongly support photobiomodulation for knee osteoarthritis, and evidence suggests similar benefits for hip OA. Red light therapy reduces pain, improves joint function, and may slow cartilage degeneration when applied consistently. While hip-specific randomized trials are limited, the shared pathophysiology of joint osteoarthritis and the successful application of RLT to knee OA suggest efficacy for hip OA as well. Always consult your physician before starting treatment.
Can red light therapy help with hip bursitis? +
Hip bursitis—inflammation of the bursa sac on the outside of the hip—responds well to red light therapy because photobiomodulation reduces inflammation, improves tissue healing, and decreases pain. Treat the area of maximum tenderness (usually the lateral hip) for 10–15 minutes, 4–5 times per week. Combined with rest, ice in acute phases, and gentle stretching, RLT can accelerate recovery from bursitis. Results are typically visible within 2–3 weeks.

⚠️ Hip Pain Safety Considerations

  • Hip replacement hardware (< 6 weeks post-surgery): Consult your surgeon before using red light therapy near implants.
  • Acute hip fracture: Do not use RLT on an acute fracture. Wait for physician clearance before starting treatment.
  • Severe, unexplained hip pain: Seek medical assessment first. Red light therapy is not a substitute for diagnosis.
  • Not a replacement for physical therapy: Combine RLT with strengthening exercises for best results.
  • Open wounds or skin conditions: Do not treat over open wounds or active skin infections.

Related Reading

Target Hip Pain Where It Starts — Without Drugs

The MOVE+ is clinically designed to reduce inflammation at the cellular level. Thousands of users have recovered mobility and resumed activities they thought were lost to hip pain. Start your recovery today.

Get MOVE+

About the Author

CB
Chris Bohler Chief Technology Officer, Kineon

Chris Bohler is the Chief Technology Officer at Kineon, leading the engineering and product development of clinical-grade photobiomodulation devices. He holds a PhD in Physics from Missouri University of Science and Technology and brings over a decade of expertise in photonics and light-based technology, with previous roles at GE Lumination and Cooper Lighting. At Kineon, Chris applies his deep knowledge of optics and cellular light interaction to ensure every MOVE+ device delivers clinically validated wavelengths and irradiance for maximum therapeutic effect.

View LinkedIn Profile →

Key Referenced Researchers

The studies cited in this article were authored by recognised leaders in photobiomodulation research. Below is a brief overview of the principal investigators whose work forms the evidence base for this guide.

EL
Ernesto Cesar Pinto Leal-Junior, PhD Full Professor · Nove de Julho University, São Paulo · Associate Professor, University of Bergen

Dr. Leal-Junior has authored over 140 peer-reviewed publications in photobiomodulation — more randomised controlled trials than any other researcher in the field. His research spans sports performance, muscular fatigue, tendinopathy, and post-exercise recovery. Supported by USD 3M+ in grants, he leads the Laboratory of Phototherapy and Innovative Technologies in Health (LaPIT) in Brazil.

View publications →
MH
Michael R. Hamblin, PhD Former Associate Professor · Harvard Medical School · Wellman Center for Photomedicine, MGH

Dr. Hamblin is one of the world's foremost authorities on photobiomodulation, with over 720 peer-reviewed publications, an h-index of 143, and more than 80,000 citations. As Principal Investigator at the Wellman Center for Photomedicine, Massachusetts General Hospital, his research established the foundational cellular mechanisms by which red and near-infrared light modulates inflammation, accelerates tissue repair, and supports neural recovery.

View publications →